Article

Understanding dry eye disease

Research into the etiology of dry eye syndrome has painted a picture of a highly complex disease that has evolved over the decades. Exhaustive efforts have been expended on shedding light on the mechanisms of dry eye disease. Nevertheless, as more is learned, more questions arise.

Key Points

Debate about the causes of dry eye began in the 1940s with Dr. Henrik Sjögren suggesting a force was pulling water across the ocular surface. The importance of tear film osmolarity later leapt to the forefront as a factor in the rates of tear production and tear film evaporation, which was supported by subsequent observations that upheld the role of tear film osmolarity in dry eye. The theory that inflammation caused dry eye entered the debate, but was negated early on and did not resurface for decades. In the 1980s, Jeffrey Gilbard, MD, R. Linsy Farris, MD, and colleagues reported that dry eye disease is dependent on and proportional to the increase in tear film osmolarity. They said that tear film osmolarity increases as the result of any condition that decreases tear production, including lacrimal gland disease, any condition that decreases corneal sensation, or any condition that increases tear film evaporation, including enlarged palpebral fissure widths or meibomian gland dysfunction.

Study group

Creation of the Dysfunctional Tear Syndrome Study Group was an early effort by dry eye clinicians to develop a plan to diagnose and treat patients with dry eye. The consensus panel comprised 17 international authorities who met in the fall of 2003 at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.